HEMOGLOBIN SUBTYPE - NEONATAL SCREENING - ANVISA Registration 10298910184
Access comprehensive regulatory information for HEMOGLOBIN SUBTYPE - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10298910184 and manufactured by manufacturer not specified. The registration is held by REVVITY DO BRASIL LTDA with validity until Oct 21, 2034.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 3 companies making the same product including TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDA, SEBIA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
10298910184
25351373258202459
00351210000124
Company Information
Dates and Status
Oct 21, 2024
21/10/2034
09/18/2025 19:00:01
HEMOGLOBINA SUBTIPO - TRIAGEM NEONATAL
Famรญlia CAPI 3 NEONAT Hb
Not specified
80416660140
Mar 06, 2023
HEMOGLOBINA SUBTIPO - TRIAGEM NEONATAL
Famรญlia CAPI 3 NEONAT Hb
SEBIA
80416660140
Mar 06, 2023
HEMOGLOBINA SUBTIPO - TRIAGEM NEONATAL
KIT ULTRA SCREENING GENESYS
TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDA
81733730001
May 20, 2019
HEMOGLOBINA SUBTIPO - TRIAGEM NEONATAL
VARIANT nbs Sickle Cell Program
BIO-RAD LABORATORIES, INC
80020690277
Jan 30, 2012
HEMOGLOBINA SUBTIPO - TRIAGEM NEONATAL
VARIANT nbs Sickle Cell Program
Not specified
80020690277
Jan 30, 2012

